CD8+ Tumor-Infiltrating Lymphocytes in Head and Neck Cancer: A Review
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.CD8+ tumor-infiltrating lymphocytes (TILs) are a promising prognostic tool in head and neck cancer. Higher CD8+ TIL levels correlate with better survival and treatment response, particularly to immunotherapy.
Area Of Science
- Oncology
- Immunology
- Pathology
Background
- CD8+ tumor-infiltrating lymphocytes (TILs) are crucial immune cells within the tumor microenvironment.
- Their role as prognostic and predictive biomarkers in various cancers is increasingly recognized.
Purpose Of The Study
- To review the current literature on CD8+ TILs in head and neck squamous cell carcinoma (SCC).
- To evaluate the prognostic and predictive value of CD8+ TILs in guiding patient management for head and neck SCC.
Main Methods
- Systematic analysis of published meta-analyses and clinical trials on CD8+ TILs in head and neck SCC.
- Review of studies evaluating the association between CD8+ TILs and patient outcomes, including survival and treatment response.
Main Results
- Consistent positive associations between elevated CD8+ TILs and improved overall survival across head and neck sites.
- CD8+ TILs predict response to immunotherapy and chemoradiation, with higher pretreatment frequencies identifying likely responders to neoadjuvant therapies.
- Elevated CD8+ TIL infiltration is observed in treatment responders during and after therapy.
Conclusions
- CD8+ TILs show significant prognostic and predictive value in head and neck SCC.
- Wider clinical adoption is hindered by the need for standardized measurement guidelines and validation.
- Future research should focus on CD8+ TIL subpopulations and biomarker-driven treatment selection.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
